21 May 2013
Keywords: celltech, zavesca, cleared, fda, its, partner, actelion
Article | 11 August 2003
Celltech and its partner Actelion have revealed that the US Food and Drug Administration has granted marketing authorization for Zavesca ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.